MedTrace Logo

Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE

NCT05357404 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2870

Last updated 2025-02-07

No results posted yet for this study

Summary

The PREVUE-VALVE study will establish reliable, population-based estimates of Valvular Heart Disease (VHD) prevalence among older Americans and allow for the development and validation of several innovative tools to aid in the detection and diagnosis of Valvular Heart Disease (VHD).

Conditions

  • Valvular Heart Disease

Sponsors & Collaborators

  • CVS Caremark

    collaborator INDUSTRY

  • Hawthorne Effect Inc.

    collaborator OTHER

  • Columbia University

    collaborator OTHER

  • Vanderbilt University Medical Center

    collaborator OTHER

  • University of Michigan

    collaborator OTHER

  • Walgreens

    collaborator INDUSTRY

  • Cardiovascular Research Foundation, New York

    lead OTHER

Principal Investigators

  • David J Cohen, MD · CardioVascular Research Foundation

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-21
Primary Completion
2025-01-31
Completion
2025-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05357404 on ClinicalTrials.gov